Stereotaxis is trading 5.26% lower at $1.08, with no confirmed company-specific announcement or other clear catalyst identified for the decline on October 13, 2026. - Recent coverage mentions successful initial procedures using the MAGiC Sweep catheter, but that earlier product news does not explain the drop. - Healthcare shares are under pressure, though available evidence does not establish that this drove Stereotaxis’s move. - The broader market is nearly flat, offering no strong explanation either.